Search for: "Boehringer-Ingelheim"
Results 61 - 80
of 441
Sorted by Relevance
|
Sort by Date
25 Jul 2012, 12:42 pm
Boston is accusing Boehringer Ingelheim of failing to adequately warn patients about the risks involved with taking the anticoagulant. [read post]
13 Nov 2013, 6:52 am
Merlino filed a lawsuit against Boehringer Ingelheim Pharmaceuticals and various subsidiaries. [read post]
28 Mar 2007, 5:25 am
Another little IP gem from online subscription service LexisNexis Butterworths is the Chancery Division for England and Wales decision on Monday of Mr Justice Patten in Boehringer Ingelheim Ltd v Vetplus Ltd, so far unreported on BAILII.This was an application by Boehringer for ex parte interim injunctive relief to stop Vetplus publishing an advertisement and a press release in various journals relating to one of its products. [read post]
1 Feb 2007, 4:56 pm
The government announced that it was joining a qui tam lawsuit under the False Claims Act against the company Boehringer Ingelheim Roxane, Inc. [read post]
27 Jun 2008, 6:35 am
Barr Pharmaceuticals Inc. and Mylan Inc. invalidated a patent (4,886,812) of Boehringer Ingelheim on Mirapex in D. [read post]
31 Oct 2014, 10:39 pm
Recently, NOACs have hit the market with FDA approval and are earning record profits for their respective manufacturers (Boehringer Ingelheim, Johnson & Johnson and Pfizer/Bristol Myers Squibb). [read post]
19 Aug 2013, 8:39 am
Boehringer Ingelheim Corp. [read post]
6 Aug 2014, 6:52 am
Medical Journal Blasts Pradaxa Manufacturer for Marketing Practices The British Medical Journal published a scathing report of Pradaxa manufacturer Boehringer Ingelheim’s marketing practices, with four reports suggesting that the drug company intentionally withheld important safety data on the blood thinner. [read post]
5 Mar 2014, 8:56 am
Unsealed Court Documents Show Pradaxa Information Withheld from FDA Unsealed court documents in a Pradaxa injury case show that the manufacturer, Boehringer Ingelheim GmbH did not disclose a data analysis to US regulators, which indicated that their blood thinner, which was touted as safer than their leading competitor warfarin, may have caused more fatal bleeding after it […] [read post]
19 Feb 2014, 10:43 am
2,000 Lawsuits Against Pradaxa Manufacturer Move Forward in the US German pharmaceutical manufacturer Boehringer Ingelheim reported on Thursday, February 13th, that the company faces more than 2,000 lawsuits in the United States in relation to its stroke prevention medication, Pradaxa, because the drug reportedly caused severe and even fatal bleeding. [read post]
4 Mar 2015, 1:32 pm
Last week, MBBP’s Scott Bleier attended a panel discussion hosted by the Johnson & Johnson Boston Innovation Center, which featured three corporate venture capitalists from Sanofi-Genzyme Bioventures, Boehringer Ingelheim Venture USA Inc. and Johnson & Johnson Development Corp. [read post]
3 Apr 2012, 10:23 pm
Boehringer-Ingelheim Pharmaceuticals (N.J. [read post]
4 Jan 2016, 3:30 am
In fact, several of the companies new to this year’s ranking of top innovators have been around a lot longer than Amazon, among them: Boehringer Ingelheim, Chevron, Exxon Mobil, Johnson Controls, Thales, and Yamaha. [read post]
28 Jul 2008, 1:36 pm
The trials will be used by the 200-plus plaintiffs and defendant Boehringer Ingelheim Pharmaceuticals to determine the strengths and weaknesses of their respective cases. [read post]
8 Dec 2008, 12:17 pm
Recent layoffs reported in the drug industry include Sanofi (650 sales reps);Novartis (550 U.S. salespersons);Merck (8,000); Wyeth (2,440); GSK (1,000); Schering-Plough (5,500);and Boehringer Ingelheim (200). [read post]
15 Jul 2007, 6:11 pm
Boehringer Ingelheim Pharma GmbH Co. [read post]
6 Nov 2013, 9:35 pm
The UK Patents Court recently issued a judgement which referred four questions to the CJEU in the case Actavis Group v Boehringer Ingelheim that aim to clarify how the SPC Regulation ought to be interpreted in respect of products having combinations of active ingredients. [read post]
26 Dec 2012, 1:35 pm
A Look At The Events And The Evidence Leading Up To This Latest FDA Action Concerning The Safety Of Pradaxa (Posted by Tom Lamb at DrugInjuryWatch.com) We set the stage with this December 19, 2012 drug company press release, "Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
14 Sep 2012, 4:49 pm
As this blog and other media sources have reported recently, the rash of lawsuits against Pradaxa may finally be having an affect, not only on the drug's manufacturer, the German company Boehringer Ingelheim, but also on the entire market for blood thinning drugs. [read post]
5 Apr 2008, 10:48 pm
Spiriva, a pulmonary drug marketed by Pfizer and Boehringer Ingelheim Pharmaceutical, appears to increase the risk of stroke, according to a public warning from the the U.S. [read post]
